Nixon Peabody
Bank of America
You are here:  Home  >  Central Coast Health Watch  >  Current Article

Amgen stock drops despite strong earnings

By   /   Friday, July 28th, 2017  /   Comments Off on Amgen stock drops despite strong earnings

    Print       Email
Amgen stock tumbled nearly 3 percent on July 26, despite reporting an increase in its second quarter net income to $2.15 billion, bringing it up to $4.74 billion for the first half of 2017. Total revenues rose 2 percent, including $100 million in product sales and $22 million in other revenues, compared to the same…


    This article is only available to Business Times subscribers
  • Subscribers: LOG IN or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Developer plans to add 1,270 homes to the Nipomo region

Read More →